US$ 26.89
eli lilly glp 1 analog Molecular Glue RO OFFERS ELI LILLY'S FOUNDAYO™,
Description
Liraglutide (NN2211) is a long-acting GLP-1 receptor agonist used to treat type 2 diabetes and obesity (Victoza, Saxenda)

Purpose of Review The development of long-acting incretin receptor agonists represents a significant advance in the fight against the concurrent epidemics of type 2 diabetes mellitus (T2DM) and obesity

Click here to read this latest analysis of LLY stock.

Easily toss them in your bag, purse, or gym bag for instant nutrition anytime, anywhere

Product Overview

Start your journey to a healthier you today.